Hexagon Nutrition financials

·Pharma & HealthChart ›
Latest results Q1 FY27 · Apr–Jun 2026
Revenue
₹104cr 
Net profit
₹8.1cr 
EBITDA margin
11.3% 
EPS
₹0.67 

Quarterly results

Every quarter ›
₹ croreQ1 FY27Year beforeChange
Revenue104——
EBITDA11.7——
EBITDA margin11.3%——
Profit before tax10.6——
Net profit8.1——
EPS₹0.67——

Over time

Q1 FY27 · Apr–Jun 2026latest
Revenue₹104 crNet profit₹8.1 crNet margin7.7%

Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.

Key numbersby financial year

₹ crore except per share
Tap a line for its trendCurrentlast closeFY26Mar 2026
626—
53.253.2
30.330.3
603—
383383
52.652.6
13.8%13.8%
43.043.0
37.937.9
9.9%9.9%
₹3.43₹3.43
6.26.2
−7.4−7.4
−1.2−1.2
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEXAGON₹56.59

Hexagon Nutrition Limited

· Pharma & Health
₹ CroreMcap ₹626 Cr
HighlightsEnterprise ValueMultiplesPer ShareAnnuals · FY-end closes
In ₹ Crore except Per Share
12 Months Ending
FY26
31/03/2026
Current
last close
Market Capitalization—626.1
- Cash, Equiv & ST Investments53.253.2
+ Total Debt30.330.3
Enterprise Value—603.2
Revenue382.6382.6
EBITDA52.652.6
Margin %13.7513.75
EBIT43.043.0
Net Income37.937.9
Margin %9.919.91
EPS, Adj (current shares)3.433.43
Cash from Operations6.26.2
Capital Expenditures-7.4-7.4
Free Cash Flow-1.2-1.2
Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Hexagon Nutrition financials and key ratios

Prices at the 29 October 2026 close · figures from the company's filings with NSE

Hexagon Nutrition (NSE: HEXAGON) had a market capitalisation of ₹705 crore at the 29 October 2026 close (₹57.32 a share) and a price-to-book ratio of 3.02. In FY26 its consolidated net profit was ₹37.9 crore on revenue of ₹383 crore; in Q1 FY27 (April–June 2026) it was ₹8.1 crore. Its debt-to-equity ratio was 0.13 on 31 March 2026. Promoters held 64.36% of the shares on 30 September 2026.

Share price used
₹57.32 · 29 October 2026 close
Latest balance sheet
31 March 2026
Shareholding pattern
30 September 2026

Hexagon Nutrition at a glance · consolidated

Market cap
₹705 Crat ₹57.32 · 29 Oct close
PE ratio
n/a
Price to book (PB)
3.02book value ₹18.98 a share
Debt to equity
0.13net cash ₹25 Cr
Promoter holding
64.36%+0.1 pts vs 30 Jun 202630 September 2026
Net worth
₹233 Cr31 March 2026

Questions

What is the Hexagon Nutrition PB ratio (price to book value)?

Hexagon Nutrition's price-to-book (PB) ratio is 3.02 at the 29 October 2026 close: a market capitalisation of ₹705 crore divided by shareholders' equity (book value) of ₹233 crore on 31 March 2026. That is a book value of ₹18.98 per share against a share price of ₹57.32.

What is the Hexagon Nutrition net worth?

Hexagon Nutrition's net worth — shareholders' equity in its consolidated balance sheet — was ₹233 crore on 31 March 2026. Its market value is a different figure: a market capitalisation of ₹705 crore at the 29 October 2026 close.

What is the Hexagon Nutrition book value per share?

Hexagon Nutrition's book value per share was ₹18.98 on 31 March 2026: shareholders' equity of ₹233 crore divided by the 12.29 crore shares in issue. The share price at the 29 October 2026 close was ₹57.32.

What is the Hexagon Nutrition market cap?

Hexagon Nutrition's market capitalisation was ₹705 crore at the 29 October 2026 close: 12.29 crore shares at ₹57.32 each.

Is Hexagon Nutrition debt free?

No. Hexagon Nutrition had borrowings of ₹30.3 crore on 31 March 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.13. Its cash and current investments were ₹55.3 crore, so it held net cash of ₹25 crore.

What is the Hexagon Nutrition dividend in 2026 and its record date?

In 2026, Hexagon Nutrition has declared one dividend: ₹0.30 with record date 15 September 2026.

What is the Hexagon Nutrition debt to equity ratio?

Hexagon Nutrition's debt-to-equity ratio was 0.13 on 31 March 2026: borrowings of ₹30.3 crore against total equity of ₹233 crore.

What is the Hexagon Nutrition free cash flow?

In FY26, Hexagon Nutrition generated ₹6.2 crore of cash from operations and spent ₹7.4 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of −₹1.2 crore.

What is the Hexagon Nutrition revenue and profit in FY26?

In FY26 (April 2025–March 2026), Hexagon Nutrition's consolidated net profit was ₹37.9 crore, on revenue from operations of ₹383 crore.

What is the Hexagon Nutrition EPS?

Hexagon Nutrition's basic earnings per share (EPS) were ₹3.43 in FY26.

What is the Hexagon Nutrition promoter holding?

Promoters held 64.36% of Hexagon Nutrition on 30 September 2026, up 0.07 percentage points from 64.29% the previous quarter, according to the shareholding pattern filed with NSE.

When are the Hexagon Nutrition next results?

Hexagon Nutrition has not yet announced the date of its Q2 FY27 results (July–September 2026); under SEBI's listing rules (Regulation 33) they are due by 14 November 2026.

What is the Hexagon Nutrition shareholding pattern?

On 30 September 2026, Hexagon Nutrition's shares were held by promoters 64.36%, foreign portfolio investors (FII/FPI) 0.29%, domestic institutions (DII) 4.12% (including mutual funds at 2.01%) and retail and other non-institutional investors 31.23%.

What are the Hexagon Nutrition latest quarterly results?

Hexagon Nutrition's latest results are for Q1 FY27 (April–June 2026), filed on 12 August 2026: consolidated net profit ₹8.1 crore; revenue from operations ₹104 crore.

Where do these Hexagon Nutrition figures come from?

From Hexagon Nutrition's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.

Consolidated figures from the company's filings with NSE; prices are NSE closing prices.